ZBNA
TEVA icon

Zions Bancorporation, National Association’s Teva Pharmaceuticals TEVA Stock Holding History

Zions Bancorporation, National Association’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.8K Sell
438
-114
-21% -$3.8K ﹤0.01% 836
2026
Q1 		$16.6K Hold
552
– – ﹤0.01% 781
2025
Q4 		$17.2K Hold
552
– – ﹤0.01% 748
2025
Q3 		$11.2K Sell
552
-28
-5% -$492 ﹤0.01% 670
2025
Q2 		$9.72K Hold
580
– – ﹤0.01% 698
2025
Q1 		$8.91K Buy
+580
New +$10.4K ﹤0.01% 705

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Zions Bancorporation, National Association's TEVA Position: Q2 2026 in Review

Zions Bancorporation, National Association reduced its Teva Pharmaceuticals (TEVA) stake by 21% in Q2 2026, selling an estimated $3.8K and leaving 438 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #836.

Zions Bancorporation, National Association first reported a position in TEVA in Q1 2025 and has held it in 6 quarters since. The position peaked at $17.2K in Q4 2025. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Zions Bancorporation, National Association held 438 shares of Teva Pharmaceuticals worth $14.8K as of Q2 2026.
  • Zions Bancorporation, National Association sold 114 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.8K.
  • Teva Pharmaceuticals made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #836 holding.
  • Zions Bancorporation, National Association first reported a position in Teva Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • Zions Bancorporation, National Association's Teva Pharmaceuticals position peaked at $17.2K in Q4 2025.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.